Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
KRBP Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 27, 2024
Report Source: 2024 1st Quarter Report
Kiromic Biopharma Inc. Stock Analysis KRBP
United States Health Care Nano Cap Report: Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The company is headquartered in Houston, Texas and currently employs 44 full-time employees. The company went IPO on 2020-10-16. The firm is engaged in developing an allogeneic Gamma Delta T-cell therapy featuring proprietary end-to-end bioinformatic, artificial intelligence (AI) targeting and manufacturing technologies to address solid tumors. The company has five clinical programs to study its key product candidates: Deltacel-01, Alexis-ISO-1, Alexis-PRO-1, Isocel combination, and Procel combination. Deltacel is its first allogeneic, off-the-shelf GDT cell-based product in Phase I clinical-stage. Its Procel and Isocel product candidates consist of allogeneic, engineered, off-the-shelf GDT cells, and they are in the preclinical development stage. Its Isocel product candidate consists of engineered GDTs that target Mesothelin Isoform 2, a target that has been discovered and prioritized using its Diamond AI bio-informatic platform. Its Procel product candidate consists of engineered GDTs that target PD-L1.
Read More Kiromic Biopharma Inc (KRBP) Chart
Key Statistics of Kiromic Biopharma Inc (KRBP)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.12Volume
21.00KP/E Ratio (TTM)
-52 Week Range
Market Cap
160.00KAvg. Volume
3314.28Dividend Yield
-Financial Metrics & Statements of Kiromic Biopharma Inc (KRBP)
FAQ's for Kiromic Biopharma Inc (KRBP)
- According to Musaffa’s Shariah screening methodology, Kiromic Biopharma Inc (KRBP) is currently classified as NOT HALAL as of July 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Kiromic Biopharma Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Kiromic Biopharma Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Kiromic Biopharma Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Kiromic Biopharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Kiromic Biopharma Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.